Adenovirus-mediated tissue-specific cytosine deaminase gene therapy for human hepatocellular carcinoma with different AFP expression levels

2002 ◽  
Vol 2 (2) ◽  
pp. 100-106 ◽  
Author(s):  
Xin Huang ◽  
Weiping Zhang ◽  
Hiroaki Wakimoto ◽  
Hirofumi Hamada ◽  
Xuetao Cao
Keyword(s):  
Hepatocellular Carcinoma ◽  
Gene Therapy ◽  
Cytosine Deaminase ◽  
Human Hepatocellular Carcinoma ◽  
Tissue Specific ◽  
Expression Levels ◽  
Cytosine Deaminase Gene

scholarly journals Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts

2007 ◽  
Vol 96 (12) ◽  
pp. 1871-1878 ◽  
Author(s):  
J Liu ◽  
H Harada ◽  
M Ogura ◽  
T Shibata ◽  
M Hiraoka
Keyword(s):  
Gene Therapy ◽  
Cytosine Deaminase ◽  
Tumour Xenografts ◽  
Cytosine Deaminase Gene

scholarly journals Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice

Hepatology ◽  
2005 ◽  
Vol 42 (6) ◽  
pp. 1355-1363 ◽  
Author(s):  
Hong Ma ◽  
Yanxin Liu ◽  
Shilian Liu ◽  
Ruian Xu ◽  
Dexian Zheng
Keyword(s):  
Hepatocellular Carcinoma ◽  
Gene Therapy ◽  
Human Hepatocellular Carcinoma ◽  
Adeno Associated Virus

scholarly journals TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survival

2014 ◽  
Vol 136 (4) ◽  
pp. E154-E160 ◽  
Author(s):  
Katja Piras-Straub ◽  
Khaleda Khairzada ◽  
Martin Trippler ◽  
Hideo A. Baba ◽  
Gernot M. Kaiser ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Tumor Growth ◽  
Human Hepatocellular Carcinoma ◽  
Trail Expression ◽  
Expression Levels
Sign in / Sign up

Export Citation Format

Share Document